Filing Flows › Teradyne (TER) › Q3 2025
Teradyne (TER) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 30, 2025
Teradyne (TER) reported revenue of $769M for the third quarter 2025 (Q3 2025), +4% from a year earlier and +18% from the quarter before. Operating margin was 18.9%, net earnings $120M (15.5% of revenue).
Teradyne, Q3 2025: revenue $769M (+4% year over year), operating margin 18.9%, net earnings $120M, operating cash flow $49.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $769M | +18% | +4% |
| Gross profit | $449M | +20% | +3% |
| Operating profit | $145M | +60% | -4% |
| Net earnings | $120M | +53% | -18% |
| Operating cash flow | $49.0M | -73% | -70% |
| Free cash flow | $2.4M | -98% | -98% |
What changed
Revenue was $769.2M in Q3 2025, up 4% year over year and up 18% from the previous quarter. Product was the largest line at 82% of revenue. Product added $19.2M year over year (up 3%), 60% of the total change.
Gross margin was 58.4%, down 0.8 points from a year earlier. Operating profit was $145.3M, a 18.9% margin (down 1.7 points year over year). Operating profit fell $6.8M even though revenue rose $31.9M versus a year earlier, so costs grew faster than sales. Operating expenses grew 7% against revenue growth of 4%. Net earnings were $119.6M, down 18% year over year. The effective tax rate was 16.3%.
Operating cash flow was $49.0M (down 70% year over year), 41% of net earnings. Non-cash charges added back $30.5M of depreciation and amortization and $15.5M of share-based compensation. Working capital and other items used $116.6M. Capital expenditures of $46.7M left free cash flow of $2.4M.
Questions
What was Teradyne's revenue in the third quarter 2025?
Teradyne (TER) reported revenue of $769M for the third quarter 2025 (Q3 2025), +4% from a year earlier and +18% from the quarter before.
Was Teradyne profitable in the third quarter 2025?
Operating profit was $145M (18.9% of revenue) and net earnings $120M.
Source: Teradyne 10-Q on SEC EDGAR.